Top Markets
Coin of the day
Lushang Freda Pharmaceutical Co.,Ltd. Lushang Freda Pharmaceutical Co.,Ltd.

Lushang Freda Pharmaceutical Co.,Ltd.

600223
Ранг среди акций #10388
Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development,... Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant extracts, chemical synthesis, tablets, capsules, drinks, injections, granules, and other products. The company offers its products through online and offline channels. It exports its products to North America, the European Union, Japan, South Korea, and Southeast Asia. The company was formerly known as Lushang Health Industry Development Co.,Ltd. and changed its name to Lushang Freda Pharmaceutical Co.,Ltd. in April 2023. The company was founded in 1993 and is based in Jinan, China. Lushang Freda Pharmaceutical Co.,Ltd. is a subsidiary of Shandong Commercial Group Co.,Ltd.
Цена акции
$0.83325484
Последняя синхронизация: 2026-08-28
Рыночная капитализация
$847.06M
Изменение (1 день)
0.70%
Изменение (1 год)
-26.10%
Страна
CN
Торговля Lushang Freda Pharmaceutical Co.,Ltd. (600223)

Категория

EPS для Lushang Freda Pharmaceutical Co.,Ltd. (600223)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Lushang Freda Pharmaceutical Co.,Ltd., текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Lushang Freda Pharmaceutical Co.,Ltd. с 2026 по 2026
EPS на конец каждого года
Год EPS Изменить
Недостаточно данных для указанных дат.
EPS для аналогичных компаний или конкурентов